2m 2m 2m 2m 2m 2m 2m
Evogene (EVGN)
NASDAQ
$0.59+$0.03 (+5.60%)
Price as of Aug 21, 2026 7:59 PM EDT- $20.0MMarket Cap
- -56.90%1-Year Change
- BiotechnologyIndustry
Evogene (EVGN)
$0.59+$0.03 (+5.60%)
EVGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.56 | ||
Change | +$0.002 (+0.36%) | ||
Open | $0.54 | ||
High | $0.58 | ||
Low | $0.54 | ||
Previous Close | $0.56 | ||
Volume | 1,041,957 | ||
30-Day Average Volume | 593,041 | ||
1-Week Change | -6.37% | ||
1-Month Change | 5.71% | ||
1-Year Change | -56.90% | ||
3-Year Change | -92.61% | ||
5-Year Change | -97.78% | ||
Fundamentals | |||
Shares Outstanding | 35.6M | ||
Total Assets | $20.0M | ||
Market Cap | $20.0M | ||
Enterprise Value | $7.1M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 07/25/2024 | ||
Earnings & Revenue